THW News and Press, Tekla World Healthcare Fund Shares of Beneficial Interest From 12/31/18

On December 31, 2018, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is derived from net investment income and return of capital or other capital source. The composition of this and subsequent distributions may v...

On December 31, 2018, Tekla Life Sciences Investors paid a distribution of $0.42 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and return of capital or other capital source. The composition of this and subsequent distributio...

On December 31, 2018, Tekla Healthcare Investors paid a distribution of $0.51 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions ...

On December 31, 2018, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income and return of capital or other capital source. The composition of this and subsequent distributio...

One of the major stories in the healthcare space recently is the $4.7 billion judgment against industry giant Johnson & Johnson ( JNJ ) concerning the alleged the presence of asbestos in baby powder. As might be expected, this had a devastating impact on the stock price, which plunged 10.0...

As 2018 comes to an end in only a few short weeks it seems like now might be a good time to see what had been working for 2018. This includes funds that are in varied sectors such as; healthcare, multi-sector bonds, high yield, and even a utility concentrated fund. At this point in the year, t...

Four democratic senators, Richard Blumenthal (D-CT), Kamala Harris (D-CA), Amy Klobuchar (D-MN) and Jeff Merkley (D-OR), have introduced a bill aimed at blocking drug price hikes. Specifically, it will allow the Department of Health and Human Services to prohibit price increases that it co...

In a letter to the President, Secretary of Health and Human Services Alex Azar, Treasury Secretary Steve Mnuchin and Labor Secretary Alexander Acosta outline their plan for revamping America's healthcare system. More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthca...

One of the closed-end funds that I frequently write about on this site is the Tekla World Healthcare Fund ( THW ). This fund is one of the newer offerings from Tekla Capital Management, which has made a name for itself with the excellent performance of its healthcare-focused closed-end funds...

The Wall Street Journal reports that the pace of biotech IPOs in on track for a near-record year, although many are riskier due to being in earlier stages of development. The public funding rush has been heavily influenced by the FDA's willingness to accelerate approval for promising drugs...